Massachusetts Financial Services CO Immunic, Inc. Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$14.21 - $25.3 $170,136 - $302,916
-11,973 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$14.8 - $20.37 $1,776 - $2,444
-120 Reduced 0.99%
11,973 $183,000
Q3 2020

Nov 12, 2020
BUY
$11.74 - $22.0 $141,971 - $266,046
12,093 New
12,093 $225,000

Others Institutions Holding IMUX

# of Institutions
70
Shares Held
56.2M
Call Options Held
100
Put Options Held
350K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $32.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email